Godavari Biorefineries: The Japanese Patent Office granted patent, "5-HYDROXY1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER" . The Patent no is 7869786. This patent covers a novel class of compounds that exhibit strong inhibitory effects on cancer and cancer stem cells, demonstrating significant efficacy against multiple types, including breast and prostate cancer. #GodavariBiorefineries #Japan

💀 DARK SIDE OF SHARE MARKET 💀 ₹1 Lakh Invested at IPO time in ~ 1. Ola Electric ~ ₹57000 2. IdeaForge Technology ~ ₹65000 3. Paytm ~ ₹52000 4. ACME Solar Holdings ~ ₹45000 5. R K Swamy ~ ₹55000 6. Godavari Biorefineries ~ ₹60000 7. Kiaasa Retail ~ ₹32000 8. Innovision ~ ₹56000 9. Shree Ram Twistex ~ ₹40000 10. Glottis ~ ₹55000

Godavari Biorefineries zooms on securing Japanese patent for treatment of cancer To view this stock in StockEdge, click here web.stockedge.com/share/goda…

💀 DARK SIDE OF SHARE MARKET 💀 ₹1 Lakh Invested at IPO time in ~ 1. Ola Electric ~ ₹57000 2. IdeaForge Technology ~ ₹65000 3. Paytm ~ ₹52000 4. ACME Solar Holdings ~ ₹45000 5. R K Swamy ~ ₹55000 6. Godavari Biorefineries ~ ₹60000 7. Kiaasa Retail ~ ₹32000 8. Innovision ~ ₹56000 9. Shree Ram Twistex ~ ₹40000 10. Glottis ~ ₹55000

#TERIConnects We are incredibly proud to share that Dr Ruchi Agrawal (Fellow, TERI) has been selected as a Global Biofuel Champion under the Global Biofuels Alliance (@we_gba). 🌱 Following a highly competitive international selection process, evaluated by an expert global jury from the USA, UK, Brazil, Germany, Canada, and India, Dr Agrawal's groundbreaking work places TERI within the prestigious first cohort of 15 Global Biofuel Champions representing 34 countries. Based out of our Sustainable Agriculture Division, her research focuses on "Process-Integrated Lignin Valorization from 2G Ethanol Biorefineries to Enable Carbon Credit Markets and Enhance Biofuel Economics." Congratulations to Dr Ruchi Agrawal and the entire project team driving this milestone! This recognition reinforces TERI’s commitment to pioneering research that fuels a sustainable, low-carbon future. #Fellowhsip #Bioufuel #BiofuelChampion #CleanFuel #BioEnergy

कैंसर ट्रीटमेंट से जुड़ी खोज पर इस कंपनी को मिला जापान से पेटेंट, शेयर 9% उछला, FII भी खरीद रहे हैं शेयर - godavari biorefineries stock jumps 9 percent gets japan patent for cancer treatment discovery - - The Economic Times Hindi

24 new projects to strengthen the scaleup of Europe’s bioeconomy  renewable-carbon.eu/news/?p=… #biodegradability #bioeconomy #bioplastics #biorefineries #circulareconomy #packaging #textiles #RenewableCarbon

#GODAVARIB Godavari Biorefineries jumps 4.5% after the company said the Japanese Patent Office granted a patent covering a novel compound for cancer treatment. The patent relates to compounds that demonstrated inhibitory effects on cancer and cancer stem cells.

Godavari Biorefineries Gets Japanese Patent For Cancer Treatment Compound - TradingView tradingview.com/news/reuters…

RT @iMicrocap: Interesting update from Godavari Biorefineries. The Japanese Patent Office granted patent, "5-HYDROXY1,4-NAPHTHALENEDIONE F…

Godavari Biorefineries Ltd granted patent in Japan #GodavariBiorefineries #Patent #Japan equitybulls.com/category.php…

📊 Sensex Today | Market Update ▪️ Godavari Biorefineries secures Japanese patent for cancer treatment compound. Godavari Biorefineries Ltd.: 302.00 (6.19%) #StockMarketIndia #Nifty50

GODAVARI BIOREFINERIES: CO. GRANTED PATENT BY JAPANESE PATENT OFFICE FOR "5-HYDROXY-1,4-NAPHTHALENEDIONE" IN CANCER TREATMENT; PATENT SHOWS STRONG INHIBITORY EFFECTS ON CANCER AND STEM CELLS.

RT @iMicrocap: Interesting update from Godavari Biorefineries. The Japanese Patent Office granted patent, "5-HYDROXY1,4-NAPHTHALENEDIONE F…

"This will be apparent from this quarter onwards." Samir Somaiya, Chairman & MD, Godavari Biorefineries. After a transition in FY26, mgmt believes FY27 is when the benefits of specialty chemicals, debottlenecking and the new grain distillery start becoming visible. Q4FY26Call

🚨 #GODAVARIBIOREFINERIES IN FOCUS 🧬 Godavari Biorefineries has been granted a patent by the Japanese Patent Office (JPO) for "5-Hydroxy-1,4-Naphthalenedione", a novel compound with potential applications in cancer treatment. 🔬 Key Highlights: ✅ Patent granted by the Japanese Patent Office ✅ Covers 5-Hydroxy-1,4-Naphthalenedione and its therapeutic applications ✅ Research indicates strong inhibitory effects on cancer cells ✅ Also demonstrates activity against cancer stem cells, a key area in oncology research ✅ Strengthens the company's intellectual property portfolio in high-value life sciences and specialty chemicals #GodavariBiorefineries #Patent #Japan #CancerResearch

🧬 #GodavariBiorefineries secures Japan patent 🇯🇵 📢 Granted a patent in #Japan for a novel cancer treatment compound. The patent marks a significant milestone in Godavari Biorefineries' innovation journey and highlights its potential in advanced #oncology research. 🚀

📊 𝗛𝗶𝗴𝗵 𝗩𝗼𝗹𝘂𝗺𝗲 𝘄𝗶𝘁𝗵 𝗣𝗿𝗶𝗰𝗲 𝗥𝗶𝘀𝗲 Stocks in focus: Devyani International Limited, Dr. Lal Path Labs Ltd., Fabtech Technologies Limited, Godavari Biorefineries Limited, GULFOILLUB ⚡️Instant stock alerts on WhatsApp - Try FREE 👉 wegro.app/bsevg | wegro.app/nsevg

Godavari Biorefineries disclosed that the Japan Patent Office has granted a patent for: "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer" The molecule has demonstrated activity against: Cancer cells Cancer stem cells Breast cancer Prostate cancer

Interesting update from Godavari Biorefineries. The Japanese Patent Office granted patent, "5-HYDROXY1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER."